Nascent Biotech Statistics

Total Valuation

Nascent Biotech has a market cap or net worth of 8.07 million. The enterprise value is 8.08 million.

Market Cap	8.07M
Enterprise Value	8.08M

Important Dates

The next estimated earnings date is Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Nascent Biotech has 172.20 million shares outstanding. The number of shares has increased by 30.53% in one year.

Shares Outstanding	172.20M
Shares Change (YoY)	+30.53%
Shares Change (QoQ)	+0.62%
Owned by Insiders (%)	50.31%
Owned by Institutions (%)	0.06%
Float	85.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.20
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.31

Current Ratio	0.31
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-854.34%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.25% in the last 52 weeks. The beta is -3.27, so Nascent Biotech's price volatility has been lower than the market average.

Beta (5Y)	-3.27
52-Week Price Change	-67.25%
50-Day Moving Average	0.05
200-Day Moving Average	0.11
Relative Strength Index (RSI)	49.33
Average Volume (20 Days)	127,082

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	-297,626
Operating Income	-2.09M
Pretax Income	-1.92M
Net Income	-1.92M
EBITDA	n/a
EBIT	-2.09M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 47,391 in cash and 59,000 in debt, giving a net cash position of -11,609 or -0.00 per share.

Cash & Cash Equivalents	47,391
Total Debt	59,000
Net Cash	-11,609
Net Cash Per Share	-0.00
Equity (Book Value)	-514,540
Book Value Per Share	-0.00
Working Capital	-514,540

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.35M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nascent Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.53%
Shareholder Yield	-30.53%
Earnings Yield	-25.14%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a